基于密切值法的国内外医药制造企业技术创新能力对比研究
|
摘要
医药制造企业的发展前景与战略方向与其技术创新能力密切相关。以专利为切入点,建立技术创新立项、质量、效率三大维度共11项细化指标,采用密切值法对国内外医药行业创新实力进行对比与排序。实证研究发现,近年我国医药行业专利数量稳步增长,但增速后劲有限,高质量技术创新较少,团队合作力度尚待提升。
The development prospects and strategic directions of pharmaceutical manufacturing companies are closely related to their technological innovation capabilities. Taking patent as the entry point, this article establishes 11 refinement indexes in the three dimensions of technological innovation project establishment, quality and efficiency,and uses the close value method to compare and rank innovation strengths of domestic and foreign pharmaceutical industries. Empirical studies have concluded that the number of patents in the pharmaceutical industry in China has steadily increased in recent years, but the growth momentum is limited, there is less high-quality technology innovation, and team cooperation needs to be improved.
The development prospects and strategic directions of pharmaceutical manufacturing companies are closely related to their technological innovation capabilities. Taking patent as the entry point, this article establishes 11 refinement indexes in the three dimensions of technological innovation project establishment, quality and efficiency,and uses the close value method to compare and rank innovation strengths of domestic and foreign pharmaceutical industries. Empirical studies have concluded that the number of patents in the pharmaceutical industry in China has steadily increased in recent years, but the growth momentum is limited, there is less high-quality technology innovation, and team cooperation needs to be improved.
引文
[1]中华人民共和国国家统计局社会科技和文化产业统计司.中国高技术产业统计年鉴2017[M].北京:中国统计出版社,2017:53.
[2]茅宁莹,李佳佳.基于Heckman选择模型的高管激励与技术创新关系研究:以医药行业上市公司为例[J].工业技术经济,2016(12):143-150.
[3]罗亚非,李敦响.基于密切值法的不同类型企业技术创新能力评价研究[J].科技进步与对策,2005(11):83-85.
[4]KIM L,NELSON R.Technology,learning,and innovation:experiences of industrializing economics[M]. Cambridge:Cambridge University Press,2000:79.
[5]FUJIMOTO T.Architecture-based comparative advantage:a design information view of manufacturing[J].Evolutionary and Institutional Economic Review,2007,4(1):23-46.
[6]梁晓捷,王兵.基于专利信息的国内外钢业产业技术创新能力评价[J].管理学报,2017,14(3):382-388.
[7]李艳华.中小企业内、外部知识获取与技术能力提升实证研究[J].管理科学,2013,26(5):19-29.
[8]王琳,魏江,饶扬德,等.知识密集服务关系嵌入与制造企业服务创新:探索性学习的中介作用和技术能力的调节作用[J].研究与发展管理, 2017,29(1):106-115.
[9]郭亮,于勃,罗晓光,等.企业技术集成能力的测量与功效[J].研究与发展管理,2016,28(3):55-66.
[10]FIGUEIREDOJ.Cross-functional emerging domains in engineering design:actor-networks and collaborative models,organizational learningandknowledgemanagement[J].Engineering Management Conference,2008,11(10):12-22.
[11]彭辉锐.后发企业从技术学习到技术能力提升[J].经营与管理, 2013(9):100-103.
[12]王昌林.企业技术创新动态能力三要素[J].企业管理,2017(5):121-123.
[13]吴伟伟,刘业鑫,于勃.技术管理与技术能力匹配对产品创新的内在影响机制[J].管理科学,2017,30(2):3-15.
[14]杨锐,刘志彪.新一轮高水平对外开放背景下中国企业技术能力升级框架与思路[J].2015(4):141-159.
[15]张颖颖,胡海青.二元技术能力、制度环境与创业绩效:来自孵化产业的实证研究[J].科技进步与对策,2016(18):113-120.
[16]龙小宁,王俊.中国专利激增的动因及其质量效应[J].世界经济,2015(6):115-142.
[17]王燕玲.基于专利分析的行业技术创新研究:分析框架[J].科学学研究,2009,4(27):622-628.
[18]吴菲菲,张广安,张辉,等.专利质量综合评价指数:以我国生物医药行业为例[J].科技进步与对策,2014,13(31):124-129.
[19]孙斌,赵婉琳,张晓阳.专利指标评价区域科技创新能力使用性研究[J].现代情报,2017,4(37):138-143..
[20]廖列法,勒孚刚.基于LDA模型和分类号的专利技术演化研究[J].现代情报,2017,5(37):13-18.
[21]何彦东,范伟,於锦,等.基于专利生命周期的技术创新信息研究[J].情报杂志,2017,7(36):72-77.
[22]PWC. The 2017 global innovation 1000 study[EB/OL].(2017-12-25)[2018-02-27].https://www.strategyand.pwc.com/innovation1000#VisualTabs1.
[23]中国药房.2017中国药品研发综合实力排行榜TOP100[EB/OL].(2017-09-11)[2018-02-27].http://www.china-pharmacy.com/6/219/26222.html.
[24]陆菊春,韩国文.企业技术创新能力评价的密切值法模型[J].科研管理,2002,1(23):54-57.
[2]茅宁莹,李佳佳.基于Heckman选择模型的高管激励与技术创新关系研究:以医药行业上市公司为例[J].工业技术经济,2016(12):143-150.
[3]罗亚非,李敦响.基于密切值法的不同类型企业技术创新能力评价研究[J].科技进步与对策,2005(11):83-85.
[4]KIM L,NELSON R.Technology,learning,and innovation:experiences of industrializing economics[M]. Cambridge:Cambridge University Press,2000:79.
[5]FUJIMOTO T.Architecture-based comparative advantage:a design information view of manufacturing[J].Evolutionary and Institutional Economic Review,2007,4(1):23-46.
[6]梁晓捷,王兵.基于专利信息的国内外钢业产业技术创新能力评价[J].管理学报,2017,14(3):382-388.
[7]李艳华.中小企业内、外部知识获取与技术能力提升实证研究[J].管理科学,2013,26(5):19-29.
[8]王琳,魏江,饶扬德,等.知识密集服务关系嵌入与制造企业服务创新:探索性学习的中介作用和技术能力的调节作用[J].研究与发展管理, 2017,29(1):106-115.
[9]郭亮,于勃,罗晓光,等.企业技术集成能力的测量与功效[J].研究与发展管理,2016,28(3):55-66.
[10]FIGUEIREDOJ.Cross-functional emerging domains in engineering design:actor-networks and collaborative models,organizational learningandknowledgemanagement[J].Engineering Management Conference,2008,11(10):12-22.
[11]彭辉锐.后发企业从技术学习到技术能力提升[J].经营与管理, 2013(9):100-103.
[12]王昌林.企业技术创新动态能力三要素[J].企业管理,2017(5):121-123.
[13]吴伟伟,刘业鑫,于勃.技术管理与技术能力匹配对产品创新的内在影响机制[J].管理科学,2017,30(2):3-15.
[14]杨锐,刘志彪.新一轮高水平对外开放背景下中国企业技术能力升级框架与思路[J].2015(4):141-159.
[15]张颖颖,胡海青.二元技术能力、制度环境与创业绩效:来自孵化产业的实证研究[J].科技进步与对策,2016(18):113-120.
[16]龙小宁,王俊.中国专利激增的动因及其质量效应[J].世界经济,2015(6):115-142.
[17]王燕玲.基于专利分析的行业技术创新研究:分析框架[J].科学学研究,2009,4(27):622-628.
[18]吴菲菲,张广安,张辉,等.专利质量综合评价指数:以我国生物医药行业为例[J].科技进步与对策,2014,13(31):124-129.
[19]孙斌,赵婉琳,张晓阳.专利指标评价区域科技创新能力使用性研究[J].现代情报,2017,4(37):138-143..
[20]廖列法,勒孚刚.基于LDA模型和分类号的专利技术演化研究[J].现代情报,2017,5(37):13-18.
[21]何彦东,范伟,於锦,等.基于专利生命周期的技术创新信息研究[J].情报杂志,2017,7(36):72-77.
[22]PWC. The 2017 global innovation 1000 study[EB/OL].(2017-12-25)[2018-02-27].https://www.strategyand.pwc.com/innovation1000#VisualTabs1.
[23]中国药房.2017中国药品研发综合实力排行榜TOP100[EB/OL].(2017-09-11)[2018-02-27].http://www.china-pharmacy.com/6/219/26222.html.
[24]陆菊春,韩国文.企业技术创新能力评价的密切值法模型[J].科研管理,2002,1(23):54-57.